Physician

Adarsh Vennepureddy, M.D

According to 2025 Medicare claims, Adarsh Vennepureddy, M.D (NPI: 1104265156) practices hematology/oncology, with the plurality of this provider's patient population coming from Sandusky, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44870-6291. Vennepureddy is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729) and IHC Quality Partners, LLC (ACO ID: A2833), participating under the MSSP model.

Vennepureddy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 360 traditional Medicare patients, billed 16,026 HCPCS/CPT codes, and received $268,282 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,603 prescription claims across 360 beneficiaries totaling $4,230,705 in drug costs, led by Xtandi (Enzalutamide). DME data shows 118 claims. Open Payments data shows 21 records totaling $2,103. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $269,182 to $268,282. In contrast, Part D prescription costs have moved sharply higher in recent years, from $4,493 to $4,230,705. For DME billing, this smaller-volume category moved sharply higher in recent years, from $3,118 to $6,703.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	169	25,217	$269,182
2020	227	2,691	$67,231
2021	228	762	$59,649
2022	296	1,101	$81,758
2023	309	1,238	$86,701
2024	360	16,026	$268,282

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	80	$4,493
2016	N/R	14	$99
2017	16	21	$861
2018	60	150	$129,824
2019	130	387	$448,456
2020	148	836	$786,253
2021	201	1,098	$1,917,693
2022	375	1,979	$4,515,567
2023	436	2,436	$6,920,027
2024	360	1,603	$4,230,705

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	34	$1,357
2020	N/R	36	$1,223
2021	N/R	14	$2,579
2022	24	200	$10,978
2023	N/R	152	$11,054
2024	N/R	118	$7,116

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	26	26	$156
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	32	32	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	118	264	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	149	169	$49
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	54	60	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	59	1,770	$680,662
Revlimid	Lenalidomide	31	742	$405,687
Cabometyx	Cabozantinib S-Malate	15	450	$381,619
Imbruvica	Ibrutinib	15	420	$261,192
Lenalidomide	Lenalidomide	25	630	$253,959

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	26	$4,700
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	46	$1,673
J9190	Injection, fluorouracil, 500 mg	N	N/R	46	$743

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$2,103	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adarsh Vennepureddy, M.D?

Tedicare shows public-source Medicare data for Adarsh Vennepureddy, M.D (NPI 1104265156), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adarsh Vennepureddy, M.D have ACO affiliation data?

Adarsh Vennepureddy, M.D is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729) and IHC Quality Partners, LLC (MSSP, ACO ID A2833).

What billing organization is linked to Adarsh Vennepureddy, M.D?

Adarsh Vennepureddy, M.D is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Adarsh Vennepureddy, M.D have Open Payments data?

Adarsh Vennepureddy, M.D has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.